Home / Inspections / 1181809

FDA Inspection 1181809 — Penn Pharmaceutical Services Limited

Penn Pharmaceutical Services Limited — FEI 1000370240

The FDA completed an inspection of Penn Pharmaceutical Services Limited on April 1, 2022 in Tredegar. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 1, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Tredegar (United Kingdom)

Additional Details

Mutual Recognition Agreement (MRA)

Facility

Other inspections at this facility

  • 1081935 (NAI Fri Feb 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1004548 (NAI Wed Mar 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1063598 (VAI Thu Jan 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 979658 (NAI Fri Jul 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 822276 (OAI Thu Feb 07 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources